Repligen Corp
Repligen Corp logo
RGEN

Repligen Corp (RGEN)

$169.135.31%

Market is closed
– opens on 8 PM, 07 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$165.81
Day's Range
$178.4
$137.21
52-Week Range
$274.09
1 month return3.81%
3 month return16.05%
1 year return27.86%
5 year return414.13%

Company Information

Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of manufacturing biological drugs. Its primary customers are biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Its corporate headquarters are located in Waltham, Massachusetts, with additional administrative and manufacturing operations worldwide. The majority of its manufacturing sites are located within the U.S. (California, Massachusetts, New Jersey and New York), and outside of the U.S. it has sites in Estonia, Germany, Ireland, the Netherlands and Sweden.
OrganizationRepligen Corp
Employees1852
CEOMr. Anthony J. Hunt
IndustryHealth Technology

Analyst Recommendation

based on 9 analysts ratings

Buy
88%
Buy
11%
Hold
0%
Sell

Based on 9 Wall street analysts offering stock ratings for Repligen Corp(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 40.66%

Current

$169.13

Target

$237.89

Recommendation Trend

Based on 9 analyst

Current1M Ago3M Ago
Buy
8
13
13
Hold
1
2
2
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
10.3B
Book Value
$33.05
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
3.21
PE Ratio
57.96
PEG Ratio
2.59
Wall Street Target Price
237.89

Valuation

Trailing PE57.96
Forward PE52.36
Price/Book (mrq)
5.07
Enterprise Value
10.2B
Enterprise Value/Revenue
12.7
Enterprise Value/Ebitda
40.09

Technicals

Beta
1.05
50 Day MA
186.38
200 Day MA
184.7

Institutional Holdings

BlackRock Inc

10.66%

Vanguard Group Inc

9.24%

T. Rowe Price Associates, Inc.

6.59%

Amvescap Plc.

3.38%

Brown Capital Management, LLC

3.16%

Sands Capital Management, LLC

2.95%

Discover more

Frequently Asked Questions

What is Repligen Corp share price today?

Can Indians buy Repligen Corp shares?

How can I buy Repligen Corp shares from India?

Can Fractional shares of Repligen Corp be purchased?

What are the documents required to start investing in Repligen Corp stocks?

What are today’s High and Low prices of Repligen Corp?

What are today’s traded volumes of Repligen Corp?

What is today’s market capitalisation of Repligen Corp?

What is the 52 Week High and Low Range of Repligen Corp?

How much percentage Repligen Corp is down from its 52 Week High?

How much percentage Repligen Corp is up from its 52 Week low?

What are the historical returns of Repligen Corp?

Who is the Chief Executive Officer (CEO) of Repligen Corp?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*